Siirt University, Medical Faculty, Obstetrics and Gynecology, Siirt, Turkey.
Akşehir State Hospital, Obstetrics and Gynecology, Konya, Turkey.
Int J Clin Pract. 2022 Sep 22;2022:2699532. doi: 10.1155/2022/2699532. eCollection 2022.
There are studies on the perinatal outcomes of COVID-19, but the audiometric effects of the maternal immune system against COVID-19 in the newborn are not clear. In this study, we aimed to investigate the relationship between the perinatal outcomes of COVID-19 positive pregnant women and the audiological outcomes of newborns.
This retrospective, single-center cohort study was conducted with 65 polymerase chain reaction (PCR) positive pregnant women and newborns and 66 normal pregnant women and newborns who were admitted between January 2020-December 2021. Pregnancy data, perinatal outcomes, and newborn hearing test results of pregnant women and newborns were recorded and compared.
A total of 131 patients were enrolled in the study. The number of normal pregnant women was 66 (50.4%) and the number of pregnant women who had COVID-19 disease was 65 (49.6%). In general, gestational week, age, parity, biochemical parameters, duration of hospital stay, week of delivery, fetal weight, and apgar scores were compared between pregnant women with COVID-19 and normal. White blood cell (WBC), neutrophil, aspartate aminotransferase (AST), and C-reactive protein (CRP) parameters were found to be significantly higher, and lymphocyte and neutrophil/lymphocyte (N/L) ratios were significantly lower ( < 0.05). There was no statistically significant difference between the two groups ( =0.001; = 1,000). The normal delivery status, the normal delivery rate in patients with COVID-19 was found to be statistically significantly higher than the cesarean section delivery status ( = 0.012). In the statistical comparison between the COVID-19 and normal pregnant groups in the cesarean section group, the gestational week, delivery week, and apgar1 scores of the pregnant women with COVID-19 were found to be significantly higher. There was no statistically significant difference between the distributions of the rate of infants with hearing impairment in the comparison with hearing tests in pregnant women with COVID-19 (=1) and normal pregnant women (=1) ( =0.001; = 1,000).
Although the negative effects of COVID-19 on pregnancy outcomes are rare, it was determined that there was no increased audiological risk factor, and the most important predictor of COVID-19 was lymphopenia.
已有研究探讨了 COVID-19 围产期结局,但母体免疫系统针对 COVID-19 对新生儿的听力影响尚不清楚。本研究旨在探讨 COVID-19 阳性孕妇的围产期结局与新生儿听力结果之间的关系。
这是一项回顾性、单中心队列研究,纳入了 2020 年 1 月至 2021 年 12 月期间收治的 65 例聚合酶链反应(PCR)阳性孕妇及其新生儿和 66 例正常孕妇及其新生儿。记录并比较了孕妇和新生儿的妊娠数据、围产期结局和新生儿听力测试结果。
共有 131 例患者入组研究。正常孕妇 66 例(50.4%),COVID-19 孕妇 65 例(49.6%)。一般来说,COVID-19 孕妇与正常孕妇的孕周、年龄、产次、生化参数、住院时间、分娩孕周、胎儿体重和阿普加评分比较,白细胞(WBC)、中性粒细胞、天门冬氨酸氨基转移酶(AST)和 C 反应蛋白(CRP)参数明显升高,淋巴细胞和中性粒细胞/淋巴细胞(N/L)比值明显降低(<0.05)。两组间差异无统计学意义( =0.001; =1,000)。正常分娩状态下,COVID-19 患者的正常分娩率明显高于剖宫产分娩状态( =0.012)。在 COVID-19 孕妇和正常孕妇的剖宫产组之间进行统计学比较时,COVID-19 孕妇的孕周、分娩孕周和阿普加 1 评分明显较高。COVID-19 孕妇与正常孕妇的听力测试结果相比,听力障碍婴儿的发生率分布差异无统计学意义( =1)( =0.001; =1,000)。
虽然 COVID-19 对妊娠结局的负面影响罕见,但确定没有增加听力损伤的危险因素,COVID-19 的最重要预测因子是淋巴细胞减少症。